Immunological evaluation of peptide vaccination for cancer patients with the HLA‐A26 allele

E-ISSN： 1349-7006|106|10|1257-1263

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.10, 2015-10, pp. : 1257-1263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of novel Lck‐derived T helper epitope long peptides applicable for HLA‐A2+ cancer patients as cancer vaccine

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1493-1498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1111-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1111-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 397-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA‐E expression in serous ovarian cancer with HLA‐E*0101*0103

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : May cover-May cover

John Wiley & Sons Inc

Access to resources Recommend Favorite